Research Square
Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer
Preprints
Ye, L; Rünger, D; Angarita, S; Hadaya, J; Baker, J; Lee, M; Thompson, C; Attai, D; DiNome, M
2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Ye, L., Rünger, D., Angarita, S., Hadaya, J., Baker, J., Lee, M., … DiNome, M. (2021). Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer. Research Square. https://doi.org/10.21203/rs.3.rs-1032846/v1
Ye, Linda, Dennis Rünger, Stephanie Angarita, Joseph Hadaya, Jennifer Baker, Minna Lee, Carlie Thompson, Deanna Attai, and Maggie DiNome. “Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer.” Research Square, 2021. https://doi.org/10.21203/rs.3.rs-1032846/v1.
Ye L, Rünger D, Angarita S, Hadaya J, Baker J, Lee M, et al. Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer. Research Square. 2021.
Ye, Linda, et al. “Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer.” Research Square, 2021. Epmc, doi:10.21203/rs.3.rs-1032846/v1.
Ye L, Rünger D, Angarita S, Hadaya J, Baker J, Lee M, Thompson C, Attai D, DiNome M. Tumor Size and Lobular Histology Predict for Higher Pathologic Nodal Stage Regardless of Clinical Presentation of Nodal Disease in Patients With Breast Cancer. Research Square. 2021.